archive_header_en_20251202185931997.png

icon_20251202200010052.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Abstract password authentication.<br>Password is written on a pocket program and name badge.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Dissecting pathophysiology of Parkinson's disease with multimodal neuroimaging

This symposium is focused on parallel and synergistic evolutions of diverse imaging modalities and biofluid analyses towards the establishment of biomarkers for Alzheimer’s and Parkinson’s diseases and allied neurodegenerative disorders. Recent advances of PET and MRI technologies have allowed diagnostic and therapeutic evaluations of brain functions and pathologies as a clinical workup, while measurements of disease-associated molecules in blood and CSF potentially offer cost-effective tests for mass screening of elderly populations. Moreover, different imaging modalities, along with neurophysiological examinations, play complementary roles in the clinical assessment of these illnesses, conjunctively covering multiple aspects of the neurofunctional and neuropathological phenotypes. The session is accordingly aimed to exchange scientific information on how the coevolution of distinct imaging and other assaying modalities could be made for the construction of next-generation diagnostic workflows.

Annual Meeting of the Japanese Society of Neurology

NEURO62

NEURO62

[NFS-01-2]Dissecting pathophysiology of Parkinson's disease with multimodal neuroimaging

Password required to view